The effectiveness of modern pharmaceuticals is deeply rooted in the precise science of chemical synthesis. For Febuxostat, a prominent medication for gout and hyperuricemia, the quality and properties of its key intermediate, p-Anisaldehyde (4-Methoxybenzaldehyde, CAS No. 123-11-5), are foundational to its therapeutic action.

As a critical p-anisaldehyde intermediate for Febuxostat synthesis, its chemical profile directly influences the final drug's efficacy. The compound's molecular structure and reactivity are carefully orchestrated within multi-step synthesis processes to produce Febuxostat, a xanthine oxidase inhibitor that effectively lowers uric acid levels. Pharmaceutical manufacturers place immense importance on the purity of this intermediate, with specifications typically set at 99.0% or higher, to ensure optimal reaction outcomes and the highest quality end product.

Understanding the detailed 4-Methoxybenzaldehyde CAS 123-11-5 properties is essential for optimizing the synthesis of Febuxostat. Its physical state as a liquid, with a density of 1.121, and its characteristic boiling point of 248-249°C, are vital parameters for process design. Furthermore, its flash point of 116°C provides crucial safety information for industrial handling and storage, ensuring that manufacturing operations are both efficient and secure.

The role of p-Anisaldehyde as a vital febuxostat precursor chemical synthesis extends to its consistent availability. The pharmaceutical industry relies on a stable supply chain to meet the global demand for gout treatments. Manufacturers often source this intermediate in bulk, commonly packaged in 200 kg drums, to support continuous production. This ensures that patients can reliably access the medication they need.

Beyond its primary use, the scientific community continues to explore the broader applications of p-Anisaldehyde, studying its various p-anisaldehyde physical and chemical properties. This research not only aids in refining its use in Febuxostat production but also opens avenues for its application in other areas of fine chemical synthesis. The meticulous control over the quality of such intermediates is a hallmark of advanced pharmaceutical manufacturing.

In essence, p-Anisaldehyde is a critical link in the chain that brings relief to individuals suffering from gout. Its role as a high-purity, reliably sourced intermediate underscores the intricate science and meticulous processes that underpin the development and production of essential medicines. By ensuring the quality of this foundational chemical, the pharmaceutical industry upholds its commitment to patient health and therapeutic excellence.